• Monday, Oct 25, 2021
  • Last Update : 11:37 am

Pakistan to import potential Covid-19 treatment from Bangladesh

  • Published at 06:43 pm May 29th, 2020
Remdesivir
FILE PHOTO: An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues. Reuters

Drug firm says it entered into agreement with Beximco Pharmaceuticals

A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from Bangladesh, it said in a stock exchange filing on Friday.

The announcement by Searle Company Limited came a day after 56 virus deaths recorded by the south Asian nation, its highest toll in a single day.

The firm said it had entered into an exclusive licensing and marketing agreement with Bangladesh's Beximco Pharmaceuticals, the first company in the world to introduce the generic variant of the drug.

"Searle Pharma is planning to import remdesivir in finished form (ready to use) to meet the country's urgent requirements," the company told the Pakistan Stock Exchange.

Remdesivir, a drug developed by Gilead Sciences, has grabbed attention as one of the most promising treatments for Covid-19, the respiratory disease caused by the virus, which has killed more than 350,000 people globally.

This month, Ferozson’s Pharma said it would make the drug in Pakistan after signing a non-exclusive licensing pact with Gilead to make and sell the drug to 127 nations, but it warned that production could take "weeks".

Pakistan's tally of infections stands at 64,000, with 1,317 deaths, but authorities estimate the disease will not peak until June.

Searle said the Bangladesh imports would ensure an immediate supply of the drug at an affordable price, helping to eliminate treatment delays by Pakistan's healthcare providers.

Gilead's patent gives the US company exclusive rights to make the antiviral. But global trade rules allow nations defined by the United Nations as least-developed countries (LDCs) to ignore the patent and make such drugs more affordable in their markets.

Bangladesh is one of 47 countries that fall in this category.

64
Facebook 61
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail